Maximizing Health Care Resource Utilization in HCC

EP: 1.Evaluating Clinical Pathway Implementation in HCC Treatment

EP: 2.The Impact of Clinical Pathways on Healthcare Resource Allocation in HCC Management

EP: 3.Identifying and Navigating Challenges Associated With Clinical Pathways in the Treatment of HCC

EP: 4.Clinical Pathways and Streamlined Decision-Making in HCC Management

EP: 5.Patient Engagement and Clinical Pathways in HCC

EP: 6.HIMALAYA Study and IMbrave150 Trial

EP: 7.Time-to-Response Correlation to HCC Treatment Effectiveness and Patient Prognosis

EP: 8.Navigating Adverse Events Associated With HCC Treatment

EP: 9.Managing Adverse Events to Sustain Continuity in HCC Treatment

EP: 10.Assessing Cost-Effective Treatment Options in HCC

EP: 11.The Decision-Making Process Behind Elective Gastroscopy (EGD) in the Treatment of HCC.

Now Viewing

EP: 12.Maximizing Health Care Resource Utilization in HCC

EP: 13.Key Toxicity Profiles in the Treatment of HCC

EP: 14.Navigating HCC Treatment-Related Toxicities

EP: 15.Toxicity Profiles and Their Impact on the Quality of Life for Patients with HCC

EP: 16.Resource Allocation Strategies in HCC Treatment

EP: 17.Key Considerations in the Management of HCC

In this segment of the video discussion focused on hepatocellular carcinoma (HCC), Kim and the panel of medical experts delved into the complexities of health care resource utilization and associated costs in HCC treatment strategies. The multidisciplinary nature of HCC treatment was emphasized, with discussions on the involvement of various specialists such as medical oncologists, hepatologists, and the need for comprehensive care in tertiary centers. The significance of preventing liver cirrhosis, hepatitis B, and hepatitis C was underscored as a potential cost-saving measure, with the panel advocating for the integration of preventive strategies such as vaccination and antiviral therapies to curtail the progression of HCC.

The conversation expanded to the interplay between value-based care principles and health care resource utilization. Kim shed light on the significance of striking a balance between effective treatment outcomes and managing the costs and resource utilization associated with HCC therapies. The experts stressed the importance of considering the burden on the patient and the potential impact on their quality of life when evaluating treatment options, underlining the need for patient-centric approaches in HCC management.

Furthermore, the panel emphasized the judicious use of diagnostic procedures and imaging studies, cautioning against overreliance on sophisticated imaging techniques when clinical examinations could suffice. They advocated for a streamlined and pragmatic approach to diagnostic processes to avoid unnecessary radiation exposure and minimize health care costs without compromising the quality of patient care. The experts urged health care providers to adhere to standardized practices and minimize redundant tests, emphasizing the need to optimize the use of health care resources for the benefit of HCC patients.

Throughout the discussion, the experts’ insights reflected a comprehensive understanding of the challenges and opportunities in HCC treatment, underscoring the importance of preventive measures, cost-effectiveness, and patient well-being. Their discourse provided valuable guidance for health care practitioners and policymakers alike, seeking to optimize HCC treatment strategies while efficiently utilizing health care resources.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.